Foghorn Therapeutics Inc (FHTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $124.12M
Last updated: Nov 17, 2026 at 11:05 AM ET
Foghorn Therapeutics Inc (FHTX) Earnings: Report Dates and Results
Foghorn Therapeutics (FHTX) is expected to report earnings on Mar 9, 2027. In the quarter ended Sep 30, 2026, Foghorn Therapeutics reported EPS of $0.80, above the -$0.23 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
FHTX has an expected report date of Mar 9, 2027.
Earnings History
Of the 26 quarters below that had an estimate, FHTX beat 10, missed 15 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $83.54M, up 925.0% from $8.15M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.80 | -$0.23 | -$0.41 - -$0.15 | +447.83% | Beat | N/A | 7 | 0 up, 2 down | Nov 9, 2026 | $83.54M |
| Jun 30, 2026 | -$0.10 | -$0.23 | -$0.32 - -$0.14 | +56.52% | Beat | N/A | 7 | 1 up, 0 down | Aug 6, 2026 | $16.07M |
| Mar 31, 2026 | -$0.29 | -$0.31 | -$0.38 - -$0.27 | +6.45% | Beat | N/A | 4 | 0 up, 1 down | May 7, 2026 | $3.27M |
| Dec 31, 2025 | -$0.37 | -$0.26 | -$0.37 - -$0.16 | -41.14% | Miss | N/A | 9 | 1 up, 0 down | Mar 11, 2026 | $9.25M |
| Sep 30, 2025 | -$0.25 | -$0.31 | -$0.40 - -$0.22 | +19.35% | Beat | N/A | 6 | 1 up, 0 down | Nov 5, 2025 | $8.15M |
| Jun 30, 2025 | -$0.28 | -$0.32 | -$0.40 - -$0.21 | +12.50% | Beat | N/A | 6 | 0 up, 3 down | Aug 5, 2025 | $7.56M |
| Mar 31, 2025 | -$0.30 | -$0.29 | -$0.34 - -$0.24 | -3.45% | Miss | N/A | 4 | 0 up, 0 down | May 14, 2025 | $5.95M |
| Dec 31, 2024 | -$0.30 | -$0.28 | -$0.37 - -$0.23 | -7.14% | Miss | N/A | 4 | 1 up, 0 down | Mar 6, 2025 | $2.86M |
| Sep 30, 2024 | -$0.31 | -$0.43 | -$0.56 - -$0.35 | +27.91% | Beat | N/A | 5 | 0 up, 0 down | Nov 4, 2024 | $7.81M |
| Jun 30, 2024 | -$0.45 | -$0.64 | -$0.82 - -$0.52 | +29.69% | Beat | N/A | 4 | 0 up, 0 down | Aug 8, 2024 | $6.89M |
| Mar 31, 2024 | -$0.59 | -$0.59 | -$0.87 - -$0.51 | 0.00% | In line | N/A | 4 | 0 up, 0 down | May 6, 2024 | $5.05M |
| Dec 31, 2023 | -$0.57 | -$0.76 | -$0.94 - -$0.63 | +25.00% | Beat | N/A | 5 | 0 up, 0 down | Mar 7, 2024 | $5.77M |
| Sep 30, 2023 | -$0.34 | -$0.65 | N/A | +47.69% | Beat | N/A | 4 | 1 up, 0 down | Nov 2, 2023 | $17.48M |
| Jun 30, 2023 | -$0.70 | -$0.69 | -$0.78 - -$0.66 | -1.45% | Miss | N/A | 4 | 0 up, 0 down | Aug 4, 2023 | $5.60M |
| Mar 31, 2023 | -$0.73 | -$0.72 | -$0.86 - -$0.66 | -1.39% | Miss | N/A | 4 | 0 up, 0 down | May 8, 2023 | $5.31M |
| Dec 31, 2022 | -$0.69 | -$0.54 | -$0.81 - -$0.33 | -27.78% | Miss | N/A | 5 | 0 up, 0 down | Mar 9, 2023 | $4.18M |
| Sep 30, 2022 | -$0.62 | -$0.50 | -$0.70 - -$0.42 | -24.00% | Miss | N/A | 4 | 0 up, 0 down | Nov 8, 2022 | $6.63M |
| Jun 30, 2022 | -$0.66 | -$0.41 | -$0.78 - -$0.33 | -60.98% | Miss | N/A | 4 | 0 up, 0 down | Aug 9, 2022 | $4.49M |
| Mar 31, 2022 | -$0.65 | -$0.47 | -$0.81 - -$0.27 | -38.30% | Miss | N/A | 4 | 0 up, 0 down | May 9, 2022 | $3.92M |
| Dec 31, 2021 | -$0.74 | -$0.49 | -$0.78 - $0.50 | -51.02% | Miss | N/A | 5 | 0 up, 0 down | Mar 10, 2022 | $713000 |
| Sep 30, 2021 | -$0.71 | -$0.59 | N/A | -20.34% | Miss | N/A | 3 | N/A | Nov 9, 2021 | $41000 |
| Jun 30, 2021 | -$0.63 | -$0.59 | N/A | -6.78% | Miss | N/A | 3 | N/A | Aug 10, 2021 | $279000 |
| Mar 31, 2021 | -$0.62 | -$0.55 | N/A | -12.73% | Miss | N/A | 3 | N/A | May 11, 2021 | $286000 |
| Dec 31, 2020 | -$1.86 | -$0.45 | -$0.70 - $0.06 | -313.33% | Miss | N/A | 4 | N/A | Mar 18, 2021 | $251000 |
| Sep 30, 2020 | -$3.12 | -$2.69 | -$3.06 - -$0.55 | -15.99% | Miss | N/A | 3 | N/A | Oct 23, 2020 | $179000 |
| Jun 30, 2020 | -$1.29 | -$2.42 | N/A | +46.69% | Beat | N/A | N/A | N/A | Sep 2, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.20, after -$1.65 the year before. It was -$6.27 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.20 | N/A |
| Dec 31, 2024 | -$1.65 | N/A |
| Dec 31, 2023 | -$2.34 | N/A |
| Dec 31, 2022 | -$2.62 | N/A |
| Dec 31, 2021 | -$2.70 | N/A |
| Dec 31, 2020 | -$6.27 | N/A |
Frequently Asked Questions About FHTX
When is Foghorn Therapeutics's next earnings date?
Foghorn Therapeutics's next earnings report is expected for Mar 9, 2027.
Did FHTX beat earnings estimates last quarter?
Yes. Foghorn Therapeutics reported EPS of $0.80 for the quarter ended Sep 30, 2026, above the -$0.23 estimate, a 447.83% surprise.
What EPS do analysts expect from FHTX next quarter?
The consensus EPS estimate for Foghorn Therapeutics for the quarter ending Dec 31, 2026 is -$0.25 from 11 analysts, with estimates from -$0.32 to -$0.17.
How often does FHTX beat earnings estimates?
Foghorn Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +61.37%.
FHTX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors